Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 16/20 | 0.75 |
| ▸ | AVPR2 | P30518 | 13/20 | 0.75 |
| ▸ | AVPR1A | P37288 | 11/20 | 0.75 |
| ▸ | AVPR1B | P47901 | 12/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cargutocin SCHEMBL1649343 | 1.00 | OXTR (0.75) | OXTRAVPR2AVPR1AAVPR1B | |
| Cargutocin SCHEMBL14060161 | 1.00 | OXTR (0.75) | OXTRAVPR2AVPR1AAVPR1B | |
| Cargutocin SCHEMBL29464048 | 1.00 | OXTR (0.75) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL19003799 | 0.92 | OXTR (0.69) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL20459016 | 0.92 | OXTR (0.69) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL17150586 | 0.92 | OXTR (0.69) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL15511850 | 0.88 | OXTR (0.88) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL15512193 | 0.88 | OXTR (0.80) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL18656317 | 0.86 | OXTR (0.74) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL17150785 | 0.86 | OXTR (0.62) | OXTRAVPR2AVPR1AAVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108236716-A | A kind of pharmaceutical composition containing oxytocin analog and its preparation method and application | 深圳翰宇药业股份有限公司 | 2018-07-03 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| CN-102580057-A | Medicine composition containing ergometrine and oxytocin analogue and preparation method | NANJING XIANYU TECHNOLOGY CO LTD | 2012-07-18 | — | — | CN | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20030125528-A1 | Process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon | HAY BRUCE A (US) | 2003-07-03 | — | — | US | claimed |
| CN-1305490-A | Improved processing for preparing schift base adducts of amines with i(o)-hydroxy aldehydes and compositions of matter based thereon | PFIZER PROD INC (US) | 2001-07-25 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-12624002-B2 | Dimers for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-05-12 | — | — | US | disclosed |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | disclosed |
| US-12595233-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260070894-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-03-12 | — | — | US | disclosed |
| WO-1996040084-A1 | COMPOSITIONS AND METHODS FOR USE OF PRESSURE SENSITIVE ADHESIVE TRANSDERMAL DEVICES CONTAINING A BIOADHESIVE HUMECTANT | NOVEN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040086-A2 | COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996024616-A1 | PROCESS FOR PREPARING CALCITONIN AND L-α-AMINOSUBERIC ACID DERIVATIVES BY ENZYMATIC CONDENSATION | LONZA AG (CH) | 1996-08-15 | — | — | WO | disclosed |
| US-5446070-A | Flexible, finite, bioadhesive, therapeutical agent in solid form | NOVER PHARMACEUTICALS, INC. (US) | 1995-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624002-B2 | Dimers for use in synthesis of peptidomimetics | GLUL, ARGLU1, ASNS | OXTR 467/4885AVPR2 1383/4885AVPR1A 1781/4885 |
| US-20030125528-A1 | Process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon | OGDH, ALDH7A1, AOX1 | OXTR 3362/4885AVPR2 1036/4885AVPR1A 1970/4885 |
| US-20260070894-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | NPR1, NGLY1, DDAH1 | OXTR 77/4885AVPR2 906/4885AVPR1A 899/4885 |
| US-12595233-B2 | Thiosemicarbazates and uses thereof | TST, THRB, HSPB1 | OXTR 1829/4885AVPR2 3683/4885AVPR1A 3992/4885 |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | MET, THRB, ABAT | OXTR 735/4885AVPR2 2697/4885AVPR1A 2696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.